← Open Payments lookup

SHARON DELLINGER: Open Payments

NPI 1932213584 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,485 in 77 payments from 16 companies in 2025. Trend: 2023 $995 · 2024 $1,636 · 2025 $1,485

Food & beverage: $1,398Education: $87
CompanyPaymentsAmount
ABBVIE INC.28$377
Janssen Biotech, Inc.7$205
Takeda Pharmaceuticals U.S.A., Inc.6$175
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$166
Phathom Pharmaceuticals, Inc.8$100
Madrigal Pharmaceuticals4$98
Celltrion USA Inc.3$72
Ardelyx, Inc.3$72
GENZYME CORPORATION2$44
Regeneron Healthcare Solutions, Inc.2$44

Products named: TREMFYA, XIFAXAN, VIBERZI, LINZESS, ENTYVIO, VOQUEZNA, REZDIFFRA, DUPIXENT.

Industry payments across CT — which companies pay providers there.